-
-
-
-
-
-
-
Mirati Therapeutics® to Report Second Quarter 2023 Financial Results and Recent Corporate Updates on August 8, 2023
-
-
-
-
-
-
-
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
-
-
-
-
-
-
-
Mirati Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Mirati Therapeutics to Report Financial Results for Third Quarter 2021 and Recent Corporate Updates on November 8, 2021
-
-
-
-
-
-
-
Mirati Therapeutics Reports Fourth Quarter And Full-Year 2020 Financial Results And Recent Corporate Updates
-
-
-
-
-
-
-
Mirati Therapeutics Reports Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Mirati Therapeutics Reports Second Quarter Financial Results
-
941,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All